Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Apr 08, 2026

Vanguard Total International Stock ETF (VXUS): Positioned for Outperformance Amid Global Shifts

Key Takeaways

  • International equities poised for outperformance with Vanguard projecting 5-7% annualized returns over the next decade versus 4-5% for U.S. stocks, driven by attractive valuations.
  • Emerging markets (26% allocation) offer growth opportunities amid lower interest rates and policy reforms, boosting sectors like technology and financials.
  • Fund flows remain robust with YTD inflows around 9%, signaling investor rotation toward diversified international exposure.
  • A weakening U.S. dollar could enhance returns for unhedged ex-U.S. equities, amplifying portfolio benefits.
  • Top holdings like Taiwan Semiconductor and ASML position VXUS for AI-driven semiconductor demand globally.
  • Low expense ratio (0.05%) and broad 8,700+ holdings provide structural efficiency amid geopolitical and currency risks.

Understanding VXUS's Portfolio and Strategy

The Vanguard Total International Stock ETF (VXUS) tracks the FTSE Global All Cap ex US Index, a float-adjusted, market-cap-weighted benchmark that captures nearly 99% of investable market capitalization outside the United States. From my perspective, this passive approach stands out because it includes over 8,700 large-, mid-, and small-cap stocks from both developed and emerging markets, delivering comprehensive global diversification that helps mitigate single-market risks.

Among the top holdings, Taiwan Semiconductor Manufacturing sits at 3.4%, followed by Samsung Electronics at 1.6%, and ASML Holding at 1.3%. This reflects significant exposure to technology (16%), alongside financial services (22%) and industrials (16%). Geographically, Europe accounts for 37%, the Pacific region 28%, emerging markets 26%, and North America 8%, with minimal allocations to the Middle East and other areas. In my view, this mix effectively reduces U.S.-centric risks while tapping into growth areas like AI supply chains, European banks, and Asian tech.

With an expense ratio of just 0.05% and low turnover at 4%, VXUS is well-structured for capturing long-term international trends. Lower valuations, with P/E ratios around 15-18x compared to U.S. peers, position it for potential outperformance as global earnings recover.

Key Catalysts Driving VXUS Forward

One thing that stands out to me is the ongoing central bank easing cycles. The European Central Bank (ECB) and Bank of Japan (BoJ) could cut rates further, benefiting the fund's 37% European exposure and 28% Pacific equities. If the Fed pauses or implements modest cuts, a weakening USD could boost unhedged returns by 5-10%, based on historical patterns in similar environments.

Emerging market reforms also catch my attention, such as Vietnam's potential upgrade and China's fiscal stimulus, which could drive inflows into the 26% EM allocation. FTSE Russell's semi-annual reviews and possible country reclassifications—like Greece moving to developed status—might trigger index rebalancing and direct billions in passive flows.

AI capex expansion supports top holdings like TSM and ASML, while commodity stabilization aids the materials sector (8%). Earnings growth in financials (22% sector weight) from normalizing rates provides additional tailwinds. YTD inflows of $9-10B underscore this momentum, which could build further amid concerns over U.S. equity concentration. I also checked this using Tickeron’s AI Screener to gauge how VXUS compares to peers.

Sector Breakdown and Macro Outlook

Global growth should broaden in 2026, with emerging markets contributing two-thirds of GDP expansion amid disinflation and rate cuts. VXUS benefits accordingly, as developed ex-U.S. markets (74%) gain from ECB and BoJ easing, while EMs leverage local policy flexibility and AI diffusion.

On the sector front, technology (16%) and financials (22%) are aligned with earnings upgrades in semiconductors and banks. Industrials (16%) may benefit from rising global capex, though energy (5%) could see volatility from supply dynamics. A stable inflation environment—declining but sticky—supports equities overall, with currency tailwinds from USD weakening boosting the index's USD-denominated performance.

Geopolitical risks remain, but the diversified exposures help mitigate them, making the FTSE Global All Cap ex US Index more resilient to macro shifts than U.S.-heavy portfolios. This is important because it positions VXUS for steadier navigation in uncertain times.

Integrating AI into My VXUS Analysis

In my research process, I rely on Tickeron’s Trend Prediction Engine, an AI-powered tool that forecasts whether assets like VXUS might trend bullish, bearish, or sideways over the next week or month. It draws from vast datasets to identify trends, potential breakouts or reversals, and covers a wide range of instruments, including ETFs. With searchable prediction categories, historical pattern recognition, and alerts for high-probability setups, it's proven valuable for both my short-term trades and longer-term positions. I’m watching VXUS closely through this lens to quantify momentum and volatility in the international space—it's a straightforward way to add data-driven insights to my strategy.

Long-Term Potential and Structural Advantages

Looking ahead over the next decade, VXUS stands to gain from structural shifts like AI adoption extending beyond U.S. hyperscalers, which favors holdings such as Taiwan Semiconductor and ASML. Demographic trends in aging Europe and Asia bolster healthcare (8%) and consumer staples, while EM urbanization fuels consumer cyclical growth (9%).

From what I see, economic cycles are tilting toward ex-U.S. markets, supported by Vanguard's higher return projections of 5-7% annualized versus 4-5% for U.S. stocks. Interest rate normalization and flows chasing value further enhance this. Technology diffusion, green energy transitions, and supply chain diversification add to the index's resilience. With strong earnings outlooks for major holdings, the FTSE Global All Cap ex US Index is capturing broadening equity leadership in a multipolar growth environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations

Related Ticker: VXUS

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


VXUS sees its Stochastic Oscillator ascends from oversold territory

On August 21, 2026, the Stochastic Oscillator for VXUS moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 62 instances where the indicator left the oversold zone. In of the 62 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 19, 2026. You may want to consider a long position or call options on VXUS as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for VXUS just turned positive on July 31, 2026. Looking at past instances where VXUS's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

VXUS moved above its 50-day moving average on August 03, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for VXUS crossed bullishly above the 50-day moving average on August 07, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VXUS advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VXUS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VXUS broke above its upper Bollinger Band on August 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VXUS entered a downward trend on August 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are AstraZeneca PLC (NYSE:AZN).

Industry description

The investment seeks to track the performance of a benchmark index that measures the investment return of stocks issued by companies located in developed and emerging markets, excluding the United States. The manager employs an indexing investment approach designed to track the performance of the FTSE Global All Cap ex US Index, a float-adjusted market-capitalization-weighted index designed to measure equity market performance of companies located in developed and emerging markets, excluding the United States. The fund invests all, or substantially all, of its assets in the common stocks included in its target index.

Market Cap

The average market capitalization across the Vanguard Total International Stock ETF ETF is 253.22B. The market cap for tickers in the group ranges from 3.51M to 676.06B. ASML holds the highest valuation in this group at 676.06B. The lowest valued company is NOVN at 3.51M.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard Total International Stock ETF ETF was 7%. For the same ETF, the average monthly price growth was 37%, and the average quarterly price growth was 21%. AZN experienced the highest price growth at 6%, while RY experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Vanguard Total International Stock ETF ETF was -14%. For the same stocks of the ETF, the average monthly volume growth was -13% and the average quarterly volume growth was -11%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 57
Price Growth Rating: 44
SMR Rating: 33
Profit Risk Rating: 46
Seasonality Score: -39 (-100 ... +100)
View a ticker or compare two or three
VXUS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Profile
Details
Category
Foreign Large Blend
Address
Vanguard Star FundsPo Box 2600 V26Valley Forge
Phone
800-523-1036
Web
www.vanguard.com
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Vanguard Total International Stock ETF (VXUS): Positioned for Outperformance Amid Global Shifts